Angiotensin IV and analogs as regulators of fibrinolysis

Douglas E. Vaughan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Angiotensin IV (VAL-TYR-ILE-HIS-PRO-PHE), a degradation product of angiotensin II previously thought to be inactive, interacts directly with endothelial cells to induce expression of PAI-1 and thereby to inhibit clot lysis attributable to endogenous t-PA. Moreover, angiotensin IV does not effect substantial physiological changes (vasoconstriction, increased blood pressure, etc.) characteristic of angiotensin II. Fibrinolysis is promoted by reducing the amount or the effect of angiotensin IV. Fibrinolysis is inhibited by providing enhanced angiotensin IV. Methods of screening candidates for antagonizing angiotensin IV are also disclosed.

Original languageEnglish (US)
Number of pages1
JournalBiotechnology Advances
Issue number3-4
StatePublished - Jan 1 1997

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Fingerprint Dive into the research topics of 'Angiotensin IV and analogs as regulators of fibrinolysis'. Together they form a unique fingerprint.

Cite this